# A Study to Investigate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of HSG4112

> **NCT04703764** · PHASE1 · COMPLETED · sponsor: **Glaceum** · enrollment: 40 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** HSG4112
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04703764
- **Lead sponsor:** Glaceum
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-15
- **Primary completion:** 2022-01-20
- **Final completion:** 2022-02-03
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-09-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04703764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04703764, "A Study to Investigate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of HSG4112". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT04703764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*